1 / 3

Cold Agglutinin Disease Market Forecast and Epidemiology Forecast

Cold Agglutinin Disease (CAD) is an uncommon autoimmune hemolytic anemia in which a well-defined, clonal low-grade lymphoproliferative disorder of the bone marrow results in erythrocyte destruction mediated by the classical complement pathway. It is mediated by cold agglutinins (CA), without any underlying disease such as aggressive lymphoma, other overt malignancies, or specific infections.

xmichael
Download Presentation

Cold Agglutinin Disease Market Forecast and Epidemiology Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cold Agglutinin Disease Market Forecast and Epidemiology Forecast Cold Agglutinin Disease (CAD) is an uncommon autoimmune hemolytic anemia in which a well-defined, clonal low-grade lymphoproliferative disorder of the bone marrow results in erythrocyte destruction mediated by the classical complement pathway. It is mediated by cold agglutinins (CA), without any underlying disease such as aggressive lymphoma, other overt malignancies, or specific infections. Cold Agglutinin Disease Epidemiology Segmentation in the 7MM ● ● ● ● ● Total Prevalent Cases of Cold Agglutinin Disease Total Diagnosed Cases of Cold Agglutinin Disease Total Gender-specific Cases of Cold Agglutinin Disease Total Type-specific Cases of Cold Agglutinin Disease Total Treated Cases of Cold Agglutinin Disease Cold Agglutinin Disease Epidemiological Insights Observed in the 7MM (2021) ● ● ● The total prevalent cases of Cold Agglutinin Disease in the 7MM were found to be 12.8k. The total diagnosed cases of Cold Agglutinin Disease in the US was estimated to be 4.3k. The total treated cases of Cold Agglutinin Disease in Japan were found to be 1.2k. Cold Agglutinin Disease Market Insight The market size of Cold Agglutinin Disease in the 7MM was found to be USD 59.9 million in 2021. Cold Agglutinin Disease Market Drivers ● ● ● Less competitive scenario Novel mechanism of action Perks related to rare diseases Cold Agglutinin Disease Market Barriers ● ● ● Lack of robust developmental pipeline Limitations related to complement inhibitors Limitations of B-cell-directed therapies Cold Agglutinin Disease Emerging Therapies The emerging drugs in the Cold Agglutinin Disease market are ● ● ● ● ● ● BIVV009 Aspaveli Empaveli LNP023 INCB050465 BIVV020, and many others

  2. Cold Agglutinin Disease Key Players The key players working in the Cold Agglutinin Disease market are ● ● ● ● ● ● Sanofi Bioverativ Sobi Apellis Pharmaceuticals Novartis Incyte Corporation, and others

More Related